Individual holder
GOLDENBERG DAVID M
US·16 granted patents·7 pending applications·362 citations·filing 1981–2012
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
23 records- 0199US8105596B2Immunotherapy of B-cell malignancies using anti-CD22 antibodiesGOLDENBERG DAVID M·Filed 2011·Granted Jan 31, 2012·54 cites·21 claims
- 0297US8722047B2Humanized anti-HLA-DR antibodiesGOLDENBERG DAVID M·Filed 2010·Granted May 13, 2014·33 cites·19 claims
- 0397US8613903B2Humanized L243 antibodiesGOLDENBERG DAVID M·Filed 2009·Granted Dec 24, 2013·35 cites·20 claims
- 0497US8333971B2Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragmentsGOLDENBERG DAVID M·Filed 2007·Granted Dec 18, 2012·29 cites·20 claims
- 0595US8216572B2Antibody therapyGOLDENBERG DAVID M·Filed 2011·Granted Jul 10, 2012·8 cites·19 claims
- 0695US8062636B2Antibody therapyGOLDENBERG DAVID M·Filed 2011·Granted Nov 22, 2011·11 cites·21 claims
- 0795US4468457AMethod for producing a CSAp tryptic peptide and anti-CSAp antibodiesGOLDENBERG DAVID M·Filed 1981·Granted Aug 28, 1984·126 cites·19 claims
- 0894US8287864B2Structural variants of antibodies for improved therapeutic characteristicsGOLDENBERG DAVID M·Filed 2009·Granted Oct 16, 2012·24 cites·21 claims
- 0992US8420783B2Method and compositions for immunotherapy of inflammatory and immune-dysregulatory diseasesGOLDENBERG DAVID M·Filed 2005·Granted Apr 16, 2013·15 cites·9 claims
- 1091US8535676B2Antibody therapyGOLDENBERG DAVID M·Filed 2012·Granted Sep 17, 2013·4 cites·20 claims
- 1191US8153433B1Mammalian cell lines for increasing longevity and protein yield from a cell cultureGOLDENBERG DAVID M·Filed 2011·Granted Apr 10, 2012·6 cites·15 claims
- 1290US8076140B2Mammalian cell lines for increasing longevity and protein yield from a cell cultureGOLDENBERG DAVID M·Filed 2010·Granted Dec 13, 2011·6 cites·14 claims
- 1388US8491896B2Anti-pancreatic cancer antibodiesGOLDENBERG DAVID M·Filed 2009·Granted Jul 23, 2013·8 cites·9 claims
- 1481US8192739B2Fusion proteins containing recombinant cytotoxic RNAsesGOLDENBERG DAVID M·Filed 2009·Granted Jun 5, 2012·3 cites·7 claims
- 1566US8420786B2Bispecific antibody targeting a complement factor or complement regulatory proteinGOLDENBERG DAVID M·Filed 2007·Granted Apr 16, 2013·0 cites·13 claims
- 1666US2012183472A1Immunotherapy of b-cell malignancies using anti-cd22 antibodiesGOLDENBERG DAVID M·Filed 2011·Application pending·0 cites
- 1763US2012114556A1Immunotherapy of autoimmune disorders using antibodies which target b-cellsGOLDENBERG DAVID M·Filed 2012·Application pending·0 cites
- 1862US2011311531A1Immunotherapy of autoimmune disorders using antibodies which target b-cellsGOLDENBERG DAVID M·Filed 2011·Application pending·0 cites
- 1961US2011286918A1Immunotherapy of autoimmune disorders using antibodies which target b-cellsGOLDENBERG DAVID M·Filed 2011·Application pending·0 cites
- 2060US2013024209A1Virtual doctor interactive cybernet systemGOLDENBERG DAVID M·Filed 2012·Application pending·0 cites
- 2159US2012230953A1Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancerGOLDENBERG DAVID M·Filed 2012·Application pending·0 cites
- 2258US9745374B2Fusion proteins containing recombinant cytotoxic RNAsesGOLDENBERG DAVID M·Filed 2012·Granted Aug 29, 2017·0 cites·16 claims
- 2353US2013078182A1Structural Variants of Antibodies for Improved Therapeutic CharacteristicsGOLDENBERG DAVID M·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GOLDENBERG DAVID M files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →